{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T20:58:45Z","timestamp":1780865925578,"version":"3.54.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07770"],"award-info":[{"award-number":["22K07770"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K07673"],"award-info":[{"award-number":["21K07673"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmp.2026.105744","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T10:03:09Z","timestamp":1770717789000},"page":"105744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumor control probability analysis in carbon-ion radiotherapy for prostate cancer considering the oxygen effect"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6428-1137","authenticated-orcid":false,"given":"Yushi","family":"Wakisaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuka","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Tsubouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Hamatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2827-5407","authenticated-orcid":false,"given":"Masashi","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7851-6213","authenticated-orcid":false,"given":"Yuki","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1486-8287","authenticated-orcid":false,"given":"Masaaki","family":"Takashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiji","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuaki","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1035","key":"10.1016\/j.ejmp.2026.105744_b0005","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130676","article-title":"Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response","volume":"87","author":"McKeown","year":"2014","journal-title":"Br J Radiol"},{"issue":"5","key":"10.1016\/j.ejmp.2026.105744_b0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00000421-200110000-00009","article-title":"Hypoxia in human prostate carcinoma: an Eppendorf PO2 study","volume":"24","author":"Movsas","year":"2001","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105744_b0015","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0090-4295(02)01858-7","article-title":"Hypoxic prostate\/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings","volume":"60","author":"Movsas","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.ejmp.2026.105744_b0020","unstructured":"Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2012."},{"issue":"1","key":"10.1016\/j.ejmp.2026.105744_b0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13046-021-02000-x","article-title":"Interfering with Tumor Hypoxia for Radiotherapy Optimization","volume":"40","author":"Telarovic","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ejmp.2026.105744_b0030","doi-asserted-by":"crossref","unstructured":"Joiner MC, van der Kogel AJ, editors. Basic clinical radiobiology. vol. 4. London: CRC press; 2018.","DOI":"10.1201\/9780429490606"},{"issue":"12","key":"10.1016\/j.ejmp.2026.105744_b0035","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrc2540","article-title":"The impact of O2 availability on human cancer","volume":"8","author":"Bertout","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"312","key":"10.1016\/j.ejmp.2026.105744_b0040","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1259\/0007-1285-26-312-638","article-title":"The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy","volume":"26","author":"Gray","year":"1953","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105744_b0045","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0360-3016(02)02963-2","article-title":"Increased radiosensitivity with chronic hypoxia in four human tumor cell lines","volume":"54","author":"Z\u00f6lzer","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105744_b0050","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/ijms21020424","article-title":"Impact of Target Oxygenation on the Chemical Track Evolution of Ion and Electron Radiation","volume":"21","author":"Boscolo","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105744_b0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/09553007414551171","article-title":"Reduction in oxygen enhancement ratio with increase in LET: tests of two hypotheses","volume":"26","author":"Alper","year":"1974","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"issue":"5549","key":"10.1016\/j.ejmp.2026.105744_b0060","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/260316a0","article-title":"Primary production of oxygen from irradiated water as an explanation for decreased radiobiological oxygen enhancement at high LET","volume":"260","author":"Baverstock","year":"1976","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105744_b0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/095530096145913","article-title":"A multiple-radical model for radiation action on DNA and the dependence of OER on LET","volume":"69","author":"Michael","year":"1996","journal-title":"Int J Radiat Biol"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105744_b0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mrrev.2011.12.007","article-title":"Changing paradigms in radiobiology","volume":"750","author":"MotherSill","year":"2012","journal-title":"Mutat Res"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105744_b0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1269\/jrr.07123","article-title":"Formation of clustered DNA damage after high-LET irradiation: a review","volume":"49","author":"Hada","year":"2008","journal-title":"J Radiat Res"},{"issue":"8","key":"10.1016\/j.ejmp.2026.105744_b0080","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3390\/cancers12082019","article-title":"Impact of Hypoxia on Carbon Ion Therapy in Glioblastoma Cells: Modulation by LET and Hypoxia-Dependent Genes","volume":"12","author":"Valable","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.ejmp.2026.105744_b0085","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.3390\/cancers15184494","article-title":"Carbon Ions for Hypoxic Tumors: are we making the Most of Them?","volume":"15","author":"Sokol","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105744_b0090","first-page":"314","article-title":"Effects of different ionizing radiations on human cells in tissue culture: IV","volume":"21","author":"Barendsen","year":"1964","journal-title":"Modification of radiation damage Radiat Res"},{"issue":"609","key":"10.1016\/j.ejmp.2026.105744_b0095","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1259\/0007-1285-51-609-712","article-title":"A heavy particle comparative study. Part III: OER and RBE","volume":"51","author":"Raju","year":"1978","journal-title":"Br J Radiol"},{"issue":"15","key":"10.1016\/j.ejmp.2026.105744_b0100","article-title":"On differences in radiosensitivity estimation: TCP experiments versus survival curves","volume":"60","author":"Stavrev","year":"2015","journal-title":"A theoretical study Phys Med Biol"},{"key":"10.1016\/j.ejmp.2026.105744_b0105","doi-asserted-by":"crossref","unstructured":"Chapman JD, Nahum AE. Radiotherapy treatment planning: linear-quadratic radiobiology. London: CRC Press; 2016.","DOI":"10.1201\/b18349"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105744_b0110","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ijrobp.2009.12.006","article-title":"Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy","volume":"79","author":"Kollmeier","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105744_b0115","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijrobp.2007.01.043","article-title":"Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer","volume":"68","author":"Vora","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105744_b0120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2007.10.004","article-title":"Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes","volume":"71","author":"Cahlon","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105744_b0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0360-3016(98)00091-1","article-title":"Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer","volume":"41","author":"Zelefsky","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105744_b0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.ejmp.2026.105744_b0135","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00066-2009-2033-5","article-title":"Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy","volume":"185","author":"Goldner","year":"2009","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105744_b0140","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.radonc.2004.12.019","article-title":"Is the alpha-beta ratio of prostate cancer really low? a prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy","volume":"75","author":"Valdagni","year":"2005","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105744_b0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00066-012-0078-3","article-title":"Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patients","volume":"188","author":"Goldner","year":"2012","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105744_b0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00066-009-1970-3","article-title":"Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. first report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial","volume":"185","author":"Goldner","year":"2009","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105744_b0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00066-013-0443-x","article-title":"Moderately hypofractionated radiotherapy for localized prostate cancer: long-term outcome using IMRT and volumetric IGRT","volume":"190","author":"Guckenberger","year":"2014","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"10.1016\/j.ejmp.2026.105744_b0160","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2007.01.067","article-title":"Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience","volume":"68","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105744_b0165","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ijrobp.2005.04.022","article-title":"Hypofractionated radiotherapy with carbon ion beams for prostate cancer","volume":"63","author":"Tsuji","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105744_b0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.radonc.2006.08.015","article-title":"Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study","volume":"81","author":"Ishikawa","year":"2006","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105744_b0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12885-020-6570-8","article-title":"Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study \u201cGUNMA0702\u201d","volume":"20","author":"Kawamura","year":"2020","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.ejmp.2026.105744_b0180","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1111\/cas.15019","article-title":"Long-term clinical outcomes after 12-fractionated carbon-ion radiotherapy for localized prostate cancer","volume":"112","author":"Sato","year":"2021","journal-title":"Cancer Sci"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105744_b0185","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0360-3016(03)00534-0","article-title":"Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha\/beta ratio","volume":"57","author":"Nahum","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"10.1016\/j.ejmp.2026.105744_b0190","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/pros.21383","article-title":"PC3 is a cell line characteristic of prostatic small cell carcinoma","volume":"71","author":"Tai","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.ejmp.2026.105744_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.102537","article-title":"Treatment planning of carbon ion radiotherapy for prostate cancer based on cellular experiments with PC3 human prostate cancer cells","volume":"107","author":"Wakisaka","year":"2023","journal-title":"Phys Med"},{"key":"10.1016\/j.ejmp.2026.105744_b0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1748-717X-6-171","article-title":"Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications","volume":"6","author":"Wenzl","year":"2011","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105744_b0205","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13014-020-01683-4","article-title":"Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition","volume":"15","author":"Sachpazidis","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejmp.2026.105744_b0210","doi-asserted-by":"crossref","unstructured":"Nahum A, Kutcher G. [Biological evaluation of treatment plans.] Handbook of radiotherapy physics\u2013theory and practice. London: Taylor & Francis; 2007, p731-88.","DOI":"10.1201\/9781420012026.ch36"},{"issue":"6","key":"10.1016\/j.ejmp.2026.105744_b0215","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1088\/0031-9155\/38\/6\/001","article-title":"A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density","volume":"38","author":"Webb","year":"1993","journal-title":"Phys Med Biol"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105744_b0220","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2005.09.043","article-title":"Examination of GyE system for HIMAC carbon therapy","volume":"64","author":"Kanai","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ejmp.2026.105744_b0225","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.ijrobp.2018.07.2009","article-title":"Tumor Control Probability Analysis for Single-Fraction Carbon-Ion Radiation Therapy of Early-Stage Non-small Cell Lung Cancer","volume":"102","author":"Paz","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105744_b0230","article-title":"Selection of carbon beam therapy: biophysical models of carbon beam therapy","volume":"59(suppl_1):i58\u2013i62","author":"Matsufuji","year":"2018","journal-title":"J Radiat Res"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105744_b0235","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1118\/1.4939260","article-title":"A validated tumor control probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy","volume":"43","author":"Walsh","year":"2016","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105744_b0240","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1137\/S1052623496303470","article-title":"Convergence properties of the Nelder-Mead simplex method in low dimensions","volume":"9","author":"Lagarias","year":"1998","journal-title":"SIAM J Optim"},{"issue":"8","key":"10.1016\/j.ejmp.2026.105744_b0245","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1088\/0031-9155\/60\/8\/3271","article-title":"Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences","volume":"60","author":"Inaniwa","year":"2015","journal-title":"Japan Phys Med Biol"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105744_b0250","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/cam4.5045","article-title":"The clinical relative biological effectiveness and prostate-specific antigen kinetics of carbon-ion radiotherapy in low-risk prostate cancer","volume":"12","author":"Kang","year":"2023","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.ejmp.2026.105744_b0255","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1667\/RR14824.1","article-title":"Oxygen Enhancement Ratio in Radiation-Induced initial DSBs by an Optimized Flow Cytometry-based Gamma-H2AX Analysis in A549 Human Cancer Cells","volume":"188","author":"Sunada","year":"2017","journal-title":"Radiat Res"},{"issue":"7","key":"10.1016\/j.ejmp.2026.105744_b0260","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/abf011","article-title":"Oxygen enhancement ratios of cancer cells after exposure to intensity modulated x-ray fields: DNA damage and cell survival","volume":"66","author":"Matsuya","year":"2021","journal-title":"Phys Med Biol"},{"issue":"9","key":"10.1016\/j.ejmp.2026.105744_b0265","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/acc720","article-title":"Modelling oxygen effects on the in- and out-of-field radiosensitivity of cells exposed to intensity-modulated radiation fields","volume":"68","author":"Matsuya","year":"2023","journal-title":"Phys Med Biol"},{"issue":"8","key":"10.1016\/j.ejmp.2026.105744_b0270","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.3390\/ijms19082228","article-title":"DNA Repair Deficient Chinese Hamster Ovary Cells Exhibiting Differential Sensitivity to Charged Particle Radiation under Aerobic and Hypoxic Conditions","volume":"19","author":"Cartwright","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejmp.2026.105744_b0275","doi-asserted-by":"crossref","first-page":"i23","DOI":"10.1093\/jrr\/rrt065","article-title":"Influence of acute hypoxia and radiation quality on cell survival","volume":"54 Suppl 1(Suppl 1)","author":"Tinganelli","year":"2013","journal-title":"J Radiat Res"},{"issue":"5","key":"10.1016\/j.ejmp.2026.105744_b0280","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1667\/0033-7587(2000)154[0485:IOAAHC]2.0.CO;2","article-title":"Inactivation of aerobic and hypoxic cells from three different cell lines by accelerated (3)He-, (12)C- and (20)Ne-ion beams","volume":"154","author":"Furusawa","year":"2000","journal-title":"Radiat Res"},{"key":"10.1016\/j.ejmp.2026.105744_b0285","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1038\/srep17016","article-title":"Kill-painting of hypoxic tumours in charged particle therapy","volume":"5","author":"Tinganelli","year":"2015","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105744_b0290","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1128\/jcm.35.3.558-562.1997","article-title":"Evaluation of the AnaeroPack system for growth of clinically significant anaerobes","volume":"35","author":"Delaney","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"Suppl 2","key":"10.1016\/j.ejmp.2026.105744_b0295","article-title":"RBE of carbon ions: experimental data and the strategy of RBE calculation for treatment planning","volume":"73","author":"Weyrather","year":"2004","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105744_b0300","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/jrr\/rrs114","article-title":"Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation","volume":"54","author":"Friedrich","year":"2013","journal-title":"J Radiat Res"},{"issue":"19","key":"10.1016\/j.ejmp.2026.105744_b0305","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1088\/0031-9155\/47\/19\/308","article-title":"Is the increased relative biological effectiveness of high LET particles due to spatial or temporal effects? Characterization and OER in V79-4 cells","volume":"47","author":"Hill","year":"2002","journal-title":"Phys Med Biol"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105744_b0310","doi-asserted-by":"crossref","first-page":"428","DOI":"10.14338\/IJPT-15-00027.1","article-title":"New Ions for Therapy","volume":"2","author":"Tommasino","year":"2016","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ejmp.2026.105744_b0315","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.radonc.2021.01.038","article-title":"Effectiveness of fractionated carbon ion treatments in three rat prostate tumors differing in growth rate, differentiation and hypoxia","volume":"158","author":"Glowa","year":"2021","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105744_b0320","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ijrobp.2024.05.004","article-title":"Irradiation with Carbon Ions Effectively Counteracts Hypoxia-related Radioresistance in a Rat Prostate Carcinoma","volume":"120","author":"Glowa","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105744_b0325","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0360-3016(03)01621-3","article-title":"Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer","volume":"58","author":"Parker","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.ejmp.2026.105744_b0330","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1158\/1078-0432.CCR-11-2711","article-title":"Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer","volume":"18","author":"Milosevic","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105744_b0335","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2007.01.018","article-title":"Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations","volume":"68","author":"Hoskin","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105744_b0340","article-title":"Advances in PET and MRI imaging of tumor hypoxia","volume":"10","author":"Gouel","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105744_b0345","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/0284186X.2013.832835","article-title":"LET-painting increases tumour control probability in hypoxic tumours","volume":"53","author":"Bassler","year":"2014","journal-title":"Acta Oncol"},{"issue":"11","key":"10.1016\/j.ejmp.2026.105744_b0350","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1088\/0031-9155\/58\/11\/3871","article-title":"Including oxygen enhancement ratio in ion beam treatment planning: model implementation and experimental verification","volume":"58","author":"Scifoni","year":"2013","journal-title":"Phys Med Biol"},{"issue":"19","key":"10.1016\/j.ejmp.2026.105744_b0355","doi-asserted-by":"crossref","first-page":"7798","DOI":"10.1088\/1361-6560\/aa88a0","article-title":"Oxygen beams for therapy: advanced biological treatment planning and experimental verification","volume":"62","author":"Sokol","year":"2017","journal-title":"Phys Med Biol"},{"issue":"20","key":"10.1016\/j.ejmp.2026.105744_b0360","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac29cc","article-title":"Adaptation of stochastic microdosimetric kinetic model to hypoxia for hypo-fractionated multi-ion therapy treatment planning","volume":"66","author":"Inaniwa","year":"2021","journal-title":"Phys Med Biol"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105744_b0365","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aafe40","article-title":"Kill painting of hypoxic tumors with multiple ion beams","volume":"64","author":"Sokol","year":"2019","journal-title":"Phys Med Biol"},{"issue":"11","key":"10.1016\/j.ejmp.2026.105744_b0370","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1088\/0031-9155\/44\/11\/201","article-title":"Dose calculations for external photon beams in radiotherapy","volume":"44","author":"Ahnesj\u00f6","year":"1999","journal-title":"Phys Med Biol"}],"updated-by":[{"DOI":"10.1016\/j.ejmp.2026.105802","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000}},{"DOI":"10.1016\/j.ejmp.2026.105802","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000}}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T20:02:48Z","timestamp":1780862568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179726000311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":74,"alternative-id":["S1120179726000311"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105744","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor control probability analysis in carbon-ion radiotherapy for prostate cancer considering the oxygen effect","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105744"}}